Available Technology

PATHOGEN SPECIFIC DIAGNOSTICS

Background
Current methods for detecting harmful, and sometimes deadly, bacteria are often time consuming and lack the required specificity to be considered reliable. This is particularly an issue for Salmonella enterica serovar Enteritidis (SE), a pathogenic subspecies of Salmonella enterica. It, like other types of pathogenic bacteria, shares high similarity to its associated non-pathogenic relatives. Serological tests employing antibodies typically cross-react between pathogenic and non-pathogenic species due to high surface structure similarity. PCR and plasmid-borne sequence-based detection methods also have difficulty distinguishing between different strains of SE due to their similarity. A method designed to overcome the obstacle of species similarity would allow for the specific detection of SE among close relatives.

Description
LLNL scientists have invented a method that is able to identify SE specific sequences that can be utilized as diagnostics markers. The method, called suppression subtractive hybridization (SSH), is a PCR-based technique that identifies restriction fragments that are present in the target strain but not other strains. A set of restriction enzymes specific to the target species isolates their associated restriction fragments which are then amplified via PCR. These PCR amplicons are then validated for specificity by testing with primer pairs from several types of phages for the target pathogen and its close relatives. In this validation test, only the specific target pathogen would pair with its known phage primers, isolating it with high specificity even among its close relatives.

Patent Abstract: 

Reference: Identification by subtractive hybridization of sequences specific for Salmonella enterica serovar Enteritidis http://aem.asm.org/content/67/11/4984.abstract

Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract no. DE-AC52-07NA27344 (Contract 44) with the U.S. Department of Energy (DOE), is offering the opportunity to secure a license to exercise patent rights for commercializing its Pathogen Specific Diagnostics technology.

Benefits 

Advantages • Accurate identification of SE specific sequences • Limited number of steps required for SE identification simplifies the process

applications 

• Detection of SE pathogen in infected eggs or chicken coops to reduce risk of food-borne illness • Rapid screening of production areas, plants, or food distribution centers to lower risk of spread of infection

Reps: 
Patent Number: 
7,442,517
Technology Type(s): 
Medical Diagnostics
Internal Laboratory Ref #: 
43019
Patent Status: 
Isued
Patent Issue Date: 
October 28, 2008
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin